HHS Announces Requested Updates to Testosterone Therapy Product Labels - Quiz - MDSpire

HHS Announces Requested Updates to Testosterone Therapy Product Labels

By
Assistant Secretary for Public Affairs (ASPA)
June 18, 2026
0 min

United States Department Of Health And Human Services

Share

Original Source(s)

United States Department Of Health And Human Services

HHS Announces Requested Updates to Testosterone Therapy Product Labels

by Assistant Secretary for Public Affairs (ASPA)
June 18, 2026

Related Content

Frontiers In Endocrinology

Analysis of metabolites in serum and villous tissue of missed abortion patients based on targeted metabolomics

by Huan Zhao, Wei Liu, Doudou Zhao, Mi Zhang, Muxi Yang, Li Shan
June 18, 2026

Frontiers In Endocrinology

Diagnostic value of tubular and glomerular biomarkers across different stages of kidney injury in patients with type 2 diabetic nephropathy

by Ming-Zhi Xiao, Xin-Xin Pang, Di Niu, Rui-Fang Chen
June 18, 2026

Frontiers In Endocrinology

Ipilimumab and nivolumab for cancer treatment: a pharmacovigilance study based on the FDA adverse event reporting system database

by Ruming Liu, Yaoyu Xiang, Xidan Hu, Min Zhang, Lujie Wang, Tao Liu, Xi Wang, Bin Qian
June 18, 2026